Artificial intelligence (AI) technology moved squarely into the clinic in 2018 with multiple US Food and Drug Administration approvals and clearances throughout the year. In addition, the agency approved its first high-profile consumer mobile apps in 2018, with the Apple Watch ECG apps and another company's contraceptive app.
On top of these product-by-product advances, the FDA moved toward a launch of an experimental "pre-certification" approach to digital health...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on In Vivo for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?